We are live on ! Find out more
SRDX

Surmodics

Delisted

SRDX was delisted on the 18th of November, 2025.

120 hedge funds and large institutions have $234M invested in Surmodics in 2015 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 45 increasing their positions, 40 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

13% more repeat investments, than reductions

Existing positions increased: 45 | Existing positions reduced: 40

4% less funds holding

Funds holding: 125120 (-5)

8% less capital invested

Capital invested by funds: $255M → $234M (-$20.3M)

31% less first-time investments, than exits

New positions opened: 9 | Existing positions closed: 13

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $30K

Holders
120
Holders Change
-5
Holders Change %
-4%
% of All Funds
3.14%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
9
Increased
45
Reduced
40
Closed
13
Calls
Puts
$30K
Net Calls
-$30K
Net Calls Change
+$139K

SRDX Hedge Fund Activity: Q4 2015 in Review

120 of the 3,824 institutional investors tracked by Wall St. Rank reported a position in Surmodics (SRDX) for Q4 2015, worth a combined $234M — down 8% from $255M a quarter earlier.

Sellers outnumbered buyers: 13 funds closed out of SRDX and 9 opened new positions — a net loss of 4 holders — while 40 trimmed existing stakes and 45 added.

The largest buyer was Renaissance Technologies, adding an estimated $2.55M. The largest seller was McKinley Capital Management, exiting entirely with an estimated $2.6M sold.

  • 120 institutional investors held Surmodics (SRDX) as of Q4 2015, down from 125 in Q3 2015.
  • Funds reported $234M of Surmodics stock for Q4 2015, down 8% quarter-over-quarter.
  • 9 funds opened new Surmodics positions in Q4 2015 and 13 closed out, a net change of -4 holders.
  • The largest Surmodics buyer in Q4 2015 was Renaissance Technologies, an estimated $2.55M added.
  • The largest Surmodics seller in Q4 2015 was McKinley Capital Management, an estimated $2.6M sold.

Based on aggregated 13F filings for Q4 2015.